Docusate Sodium Paediatric 12.5mg/5ml Oral Solution is a clear oral liquid.
Docusate Sodium Paediatric 12.5mg/5ml Oral Solution contains Docusate Sodium 12.5mg in 5ml. Docusate Sodium is a laxative.
Docusate Sodium Paediatric 12.5mg/5ml Oral Solution is a P Pharmacy Medicine. People can buy products classified as ‘pharmacy medicines’ ( P ) but only from a pharmacy and in the presence of a pharmacist. These medicines, also called ‘pharmacy-only medicines’, are not usually displayed on open shelves.
Docusate Sodium Paediatric 12.5mg/5ml Oral Solution is a laxative. It is used to prevent and treat constipation. It can also be used before a stomach X-ray such as a barium meal.
How to use Docusate Sodium Paediatric 12.5mg/5ml Oral Solution
For infants aged over 6 months: one 5ml spoonful three times a day. Dilute the medicine in a glass of flavoured drink such as fruit juice or milk and give to the infant or child to drink within 30 minutes of preparation
Children aged 2-12 years: one to two 5ml spoonfuls three times a day. Dilute the medicine in a glass of flavoured drink such as fruit juice or milk and give to the infant or child to drink within 30 minutes of preparation.
Docusate Sodium Paediatric 12.5mg/5ml Oral Solution should not be given to infants under the age of 6 months. Always read the label.
If you forget to give a dose of Docusate Sodium Paediatric 12.5mg/5ml Oral Solution, as soon as you remember, give the infant or child a dose and then continue the normal course of treatment. Do not take a double dose of either medicine to make up for a forgotten dose
When taken before a stomach X-ray, please follow the recommended instructions from your GP or pharmacist. The dose recommended is 30ml (six 5ml spoonfuls) as a single dose.
Docusate Sodium 12.5mg/5ml. Always read the label
For full details about Docusate Sodium Paediatric 12.5mg/5ml Oral Solution, please refer to the Patient Information Leaflet above.
Due to regulatory changes, the content of the Patient Information leaflet (Revised August 2022) above may vary from the one found in your medicine pack. Please compare the ‘Leaflet prepared/revised date’ towards the end of the leaflet in your pack, with the date on the document below, to establish if there have been any changes.
If you have any queries about your medication, please contact your doctor or pharmacist.
Children under 18 years
Docusate Sodium Paediatric 12.5mg/5ml Oral Solution is suitable for children aged 6 months to 12 years. Docusate Sodium Paediatric 12.5mg/5ml Oral Solution should not be given to infants under the age of 6 months. Follow your doctor’s instructions.
Do not use laxatives for longer than 1 weeks unless directed by a doctor.
Ask a doctor before use if you have:
Stop use and ask a doctor if:
Adverse events and precautions
All medicines cause adverse events and should not be used in certain circumstances and by certain people with certain health issues. Please see Patient Information Leaflet above.
Special warning: Do not use laxative products when abdominal pain, nausea, or vomiting is present unless directed by a physician. If you have noticed a sudden change in bowel movements that persists over a period of two weeks, consult a physician before using a laxative. Do not use laxative products for longer than 1 week unless told to do so by a doctor. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition; discontinue use and consult your physician. If you are pregnant or nursing a baby, seek the advice of a healthcare professional before using these products. In case of accidental overdose, seek professional healthcare assistance immediately. Keep out of children’s reach.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Patients and Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Typharm on 02037 694160.